Skip to main content


Page 31 of 37

  1. Presently, colorectal cancer (CRC) is staged preoperatively by radiographic tests, and postoperatively by pathological evaluation of available surgical specimens. However, present staging methods do not accura...

    Authors: Farshad Farshidfar, Aalim M Weljie, Karen Kopciuk, W Don Buie, Anthony MacLean, Elijah Dixon, Francis R Sutherland, Andrea Molckovsky, Hans J Vogel and Oliver F Bathe
    Citation: Genome Medicine 2012 4:42
  2. Altered networks of gene regulation underlie many complex conditions, including cancer. Inferring gene regulatory networks from high-throughput microarray expression data is a fundamental but challenging task ...

    Authors: Piyush B Madhamshettiwar, Stefan R Maetschke, Melissa J Davis, Antonio Reverter and Mark A Ragan
    Citation: Genome Medicine 2012 4:41
  3. The number of metabolites identified in human cerebrospinal fluid (CSF) has steadily increased over the past 5 years, and in this issue of Genome Medicine David Wishart and colleagues provide a comprehensive upda...

    Authors: Emanuel Schwarz, E Fuller Torrey, Paul C Guest and Sabine Bahn
    Citation: Genome Medicine 2012 4:39
  4. Human cerebral spinal fluid (CSF) is known to be a rich source of small molecule biomarkers for neurological and neurodegenerative diseases. In 2007, we conducted a comprehensive metabolomic study and performe...

    Authors: Rupasri Mandal, An Chi Guo, Kruti K Chaudhary, Philip Liu, Faizath S Yallou, Edison Dong, Farid Aziat and David S Wishart
    Citation: Genome Medicine 2012 4:38
  5. Breast cancer is the most common cancer in women worldwide, and the development of new technologies for better understanding of the molecular changes involved in breast cancer progression is essential. Metabol...

    Authors: Carsten Denkert, Elmar Bucher, Mika Hilvo, Reza Salek, Matej Orešič, Julian Griffin, Scarlet Brockmöller, Frederick Klauschen, Sibylle Loibl, Dinesh Kumar Barupal, Jan Budczies, Kristiina Iljin, Valentina Nekljudova and Oliver Fiehn
    Citation: Genome Medicine 2012 4:37
  6. The prevalence, and associated healthcare burden, of diabetes mellitus is increasing worldwide. Mortality and morbidity are associated with diabetic complications in multiple organs and tissues, including the ...

    Authors: Marta Ugarte, Marie Brown, Katherine A Hollywood, Garth J Cooper, Paul N Bishop and Warwick B Dunn
    Citation: Genome Medicine 2012 4:35
  7. Genome-wide association studies (GWAS) analyze the genetic component of a phenotype or the etiology of a disease. Despite the success of many GWAS, little progress has been made in uncovering the underlying me...

    Authors: Jerzy Adamski
    Citation: Genome Medicine 2012 4:34
  8. Metabolomics, the non-targeted interrogation of small molecules in a biological sample, is an ideal technology for identifying diagnostic biomarkers. Current tissue extraction protocols involve sample destruct...

    Authors: Meredith V Brown, Jonathan E McDunn, Philip R Gunst, Elizabeth M Smith, Michael V Milburn, Dean A Troyer and Kay A Lawton
    Citation: Genome Medicine 2012 4:33
  9. The peroxisome proliferator-activated receptors (PPARs) are a set of three nuclear hormone receptors that together play a key role in regulating metabolism, particularly the switch between the fed and fasted s...

    Authors: Zsuzsanna Ament, Mojgan Masoodi and Julian L Griffin
    Citation: Genome Medicine 2012 4:32
  10. Increasingly sophisticated measurement technologies have allowed the fields of metabolomics and genomics to identify, in parallel, risk factors of disease; predict drug metabolism; and study metabolic and gene...

    Authors: Steven L Robinette, Elaine Holmes, Jeremy K Nicholson and Marc E Dumas
    Citation: Genome Medicine 2012 4:30
  11. Human diseases can be caused by complex mechanisms involving aberrations in numerous proteins and pathways. With recent advances in genomics, elucidating the molecular basis of disease on a personalized level ...

    Authors: Yvonne Y Li and Steven JM Jones
    Citation: Genome Medicine 2012 4:27
  12. A recent report by the World Health Organization calls for implementation of community genetics programs in low- and middle-income countries (LMICs). Their focus is prevention of congenital disorders and genet...

    Authors: Stephen F Kingsmore, John D Lantos, Darrell L Dinwiddie, Neil A Miller, Sarah E Soden, Emily G Farrow and Carol J Saunders
    Citation: Genome Medicine 2012 4:25
  13. Recently, it has been proposed that epigenetic variation may contribute to the risk of complex genetic diseases like cancer. We aimed to demonstrate that epigenetic changes in normal cells, collected years in ...

    Authors: Andrew E Teschendorff, Allison Jones, Heidi Fiegl, Alexandra Sargent, Joanna J Zhuang, Henry C Kitchener and Martin Widschwendter
    Citation: Genome Medicine 2012 4:24
  14. There is a need for methods that are able to identify rare variants that cause low or moderate penetrance disease susceptibility. To answer this need, we introduce a rule-based haplotype comparison method, Hap...

    Authors: Sirkku Karinen, Silva Saarinen, Rainer Lehtonen, Pasi Rastas, Pia Vahteristo, Lauri A Aaltonen and Sampsa Hautaniemi
    Citation: Genome Medicine 2012 4:21
  15. Age-related macular degeneration (AMD) is a leading cause of blindness that affects the central region of the retinal pigmented epithelium (RPE), choroid, and neural retina. Initially characterized by an accum...

    Authors: Aaron M Newman, Natasha B Gallo, Lisa S Hancox, Norma J Miller, Carolyn M Radeke, Michelle A Maloney, James B Cooper, Gregory S Hageman, Don H Anderson, Lincoln V Johnson and Monte J Radeke
    Citation: Genome Medicine 2012 4:16
  16. Genetic variation in the protein tyrosine phosphatase non-receptor type gene 22 (PTPN22, encoding lymphoid tyrosine phosphatase, LYP) influences the risk of developing multiple autoimmune diseases, but the underl...

    Authors: Lina-Marcela Diaz-Gallo and Javier Martin
    Citation: Genome Medicine 2012 4:13
  17. Perhaps as much as two-thirds of the mammalian genome is composed of mobile genetic elements ('jumping genes'), a fraction of which is still active or can be reactivated. By their sheer number and mobility, re...

    Authors: Szilvia Solyom and Haig H Kazazian Jr
    Citation: Genome Medicine 2012 4:12
  18. Cigarette smoking is well-known to associate with accelerated skin aging as well as cardiovascular disease and lung cancer, in large part due to oxidative stress. Because metabolites are downstream of genetic ...

    Authors: Robert C Spitale, Michelle Y Cheng, Kimberly A Chun, Emily S Gorell, Claudia A Munoz, Dale G Kern, Steve M Wood, Helen E Knaggs, Jacob Wulff, Kirk D Beebe and Anne Lynn S Chang
    Citation: Genome Medicine 2012 4:14
  19. Epigenetic alterations, such as aberrant DNA methylation, are a hallmark of cancer. DNA hypermethylation of the promoter region affects, for example, the expression of tumor suppressor genes and is associated ...

    Authors: Oliver Zolk and Martin F Fromm
    Citation: Genome Medicine 2012 4:10
  20. The R620W variant in protein tyrosine phosphatase non-receptor 22 (PTPN22) is associated with rheumatoid arthritis (RA). The PTPN22 gene has alternatively spliced transcripts and at least two of the splice forms ...

    Authors: Marcus Ronninger, Yongjing Guo, Klementy Shchetynsky, Andrew Hill, Mohsen Khademi, Tomas Olsson, Padmalatha S Reddy, Maria Seddighzadeh, James D Clark, Lih-Ling Lin, Margot O'Toole and Leonid Padyukov
    Citation: Genome Medicine 2012 4:2
  21. Several theories have been proposed to conceptualize the pathological processes inherent to schizophrenia. The 'prostaglandin deficiency' hypothesis postulates that defective enzyme systems converting essentia...

    Authors: Matej Orešič, Tuulikki Seppänen-Laakso, Daqiang Sun, Jing Tang, Sebastian Therman, Rachael Viehman, Ulla Mustonen, Theo G van Erp, Tuulia Hyötyläinen, Paul Thompson, Arthur W Toga, Matti O Huttunen, Jaana Suvisaari, Jaakko Kaprio, Jouko Lönnqvist and Tyrone D Cannon
    Citation: Genome Medicine 2012 4:1
  22. Targeted therapy with tyrosine kinase inhibitors has led to a substantial improvement in the standard of care for patients with advanced or metastatic clear cell renal cell carcinoma. Because the mechanism of ...

    Authors: Ram N Ganapathi and Ronald M Bukowski
    Citation: Genome Medicine 2011 3:79
  23. Fragile X syndrome is the most common cause of inherited intellectual disability, but the underlying pathophysiology is complex and effective treatments are lacking. In a recent study of fragile X mental retardat...

    Authors: Inge Heulens, Sien Braat and R Frank Kooy
    Citation: Genome Medicine 2011 3:80
  24. Organic cation transporters (OCTs) determine not only physiological processes but are also involved in the cellular uptake of anticancer agents. Based on microarray analyses in hepatocellular carcinoma (HCC), SLC...

    Authors: Elke Schaeffeler, Claus Hellerbrand, Anne T Nies, Stefan Winter, Stephan Kruck, Ute Hofmann, Heiko van der Kuip, Ulrich M Zanger, Hermann Koepsell and Matthias Schwab
    Citation: Genome Medicine 2011 3:82

Annual Journal Metrics

  • 2022 Citation Impact
    12.3 - 2-year Impact Factor
    13.8 - 5-year Impact Factor
    2.422 - SNIP (Source Normalized Impact per Paper)
    4.851 - SJR (SCImago Journal Rank)

    2023 Speed
    9 days submission to first editorial decision for all manuscripts (Median)
    185 days submission to accept (Median)

    2023 Usage 
    4,916 Altmetric mentions

  • Peer Review Taxonomy

    This journal is participating in a pilot of NISO/STM's Working Group on Peer Review Taxonomy, to identify and standardize definitions and terminology in peer review practices in order to make the peer review process for articles and journals more transparent. Further information on the pilot is available here

    The following summary describes the peer review process for this journal:

    • Identity transparency: Single anonymized
    • Reviewer interacts with: Editor
    • Review information published: None

    We welcome your feedback on this Peer Review Taxonomy Pilot. Please can you take the time to complete this short survey.